HYPRESSIN®

Tablet, 2mg
RxActive license

Active substance (INN)

perindopril

Pharmaceutical form

Pharmaceutical formTablet
Strength2mg
PackagingUkupno 30 tableta u blisteru (3x10) u kartonskoj kutiji
ManufacturerBosnalijek d.d., Bosnia and Herzegovina
Therapeutic groupCardiovascular system (C09AA04)
Marketing authorization holderBOSNALIJEK D.D. PREDSTAVNIŠTVO CRNA GORA
Authorization dateJuly 21, 2022

Analogs in Montenegro

20

Other medicines with the same active substance

AMLESSARx
Tablet, 8mg + 10mgKrka d.d.
AMLESSARx
Tablet, 8mg + 5mgKrka d.d.
AMLESSARx
Tablet, 4mg + 10mgKrka d.d.
AMLESSARx
Tablet, 4mg + 5mgKrka d.d.
AMLESSANEORx
Tablet, 10mg + 5mgKrka d.d.
AMLESSANEORx
Tablet, 10mg + 10mgKrka d.d.
AMLESSANEORx
Tablet, 5mg + 10mgKrka d.d.
AMLESSANEORx
Tablet, 5mg + 5mgKrka d.d.
AMLEWELRx
Tablet, 8mg + 5mg + 2.5mgKrka d.d.
AMLEWELRx
Tablet, 4mg + 10mg + 1.25mgKrka d.d.
AMLEWELRx
Tablet, 4mg + 5mg + 1.25mgKrka d.d.
AMLEWELRx
Tablet, 2mg + 5mg + 0.625mgKrka d.d.
AMLEWELRx
Tablet, 8mg + 10mg + 2.5mgKrka d.d.
AMLEWELNEORx
Tablet, 10mg + 10mg + 2.5mgKrka d.d.
AMLEWELNEORx
Tablet, 5mg + 5mg + 1.25mgKrka d.d.
AMLEWELNEORx
Tablet, 10mg + 5mg + 2.5mgKrka d.d.
HYPRESSIN PLUSRx
Tablet, 2mg + 0.625mgBosnalijek d.d.
HYPRESSIN PLUSRx
Tablet, 4mg + 1.25mgBosnalijek d.d.
HYPRESSIN®Rx
Tablet, 4mgBosnalijek d.d.
HYPRESSIN®Rx
Tablet, 8mgBosnalijek d.d.
Source: CInMED register